No Detail Found!

Antibacterial activity of silver nanoparticles against carbapenem- resistant Acinetobacter baumannii clinical isolates

Author(s)
Asad Ali Shah Department of Bioinformatics and Biotechnology, Faculty of Life Sciences, Government College University Faisalabad,,Pakistan
Ijaz Ahmad Department of Microbiology, Faculty of Life Sciences, Government College University Faisalabad,,Pakistan
Muhammad Shafique Department of Microbiology, Faculty of Life Sciences, Government College University Faisalabad,,Pakistan
Abu Baker Siddique Department of Microbiology, Faculty of Life Sciences, Government College University Faisalabad,,Pakistan
Bilal Aslam Department of Microbiology, Faculty of Life Sciences, Government College University Faisalabad, Pakistan
Muhammad Usman Qamar Department of Microbiology, Faculty of Life Sciences, Government College University Faisalabad, Pakistan
Abstract
Carbapenem-resistant Acinetobacter baumannii (CRAB) produce resistance to various classes of antibiotics and left limited options for treatment. This study was designed to determine antibacterial activity of AgNPs against CRAB. Total 100 A. baumannii were collected from a tertiary care hospital, Lahore. Isolates were subcultured on blood and MacConkey agar. Preliminary identification was carried out by morphological and biochemical tests. Antibiogram was done by Kirby-Bauer disc diffusion method. Antibacterial activity of AgNPs was performed by agar well diffusion method, while minimum inhibitory concentration and minimum bactericidal concentration were determined by micro broth dilution assay. Of 100 A. baumannii, 24 were confirmed as carbapenem-resistant. These isolates were mainly recovered from tracheal secretion (8; 33%), CSF (5; 20.8%), and urine (4; 16.8%). Antibacterial activity of AgNPs revealed a maximum zone of inhibition, 22mm at 50mg/mL and 18mm at 40mg/mL by agar well diffusion method. MIC of AgNPs determined that 14 CRAB were inhibited at 12.5mg/mL and 7 at 25mg/mL. However, MBC revealed that 13 CRAB were killed at 25mg/mL and 7 at 50mg/mL. This study concluded that most of the CRAB were inhibited and killed at 12.5mg/mL and 25mg/mL, respectively. AgNPs can be used as an alternative therapeutic agent followed by their pharmacokinetics and pharmacognosy.
Publication Details
Page(s) 203-208
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 35, Issue: SUP1, Year: 2022

Request the full text from PASTIC

Keywords
A, MIC, baumannii, MBC, Carbapenem-resistant, Silver nanoparticles
References
Ababneh Q,Abulaila S,Jaradat Z S .2021 .Isolation of extensively drug resistant acinetobacter baumannii from environmental surfaces inside intensive care units. Am. J. Infect. Control., 11(1) : 1-7.
Ahmad G,Rasool N,Qamar Mu,Kosar N,Mahmood T,Imran M .2021 .Facile synthesis of 4-aryl-n-(5-methyl-1h-pyrazol-3-yl) benzamides via suzuki miyaura reaction: antibacterial activity against clinically isolated ndm-1-positive bacteria and their docking studies. Arab. J. Chem, 14(8) : 103270.
So Allend,Nakazaro G,Reis Gf,Db Pereira,Dd Pereira .2021 .Biogenic silver nanoparticle (Bio-Agnp) has an antibacterial effect against carbapenem-resistant Acinetobacter Baumannii with synergism and additivity when combined with polymyxin B. J. Appl, : 1-12.
Asif M,Alvi Ia M,Su M .2018 .Insight into acinetobacter baumannii: pathogenesis, global resistance, mechanisms of resistance, treatment options, and alternative modalities. Infect. Drug Resist, 11 : 1249-1260.
Aslam B,Wang W,Khurshid M,Muzammil S,Rasool Mh,Mkf And Baloch Z Salamat .2018 .Antibiotic resistance: A rundown of a global crisis. Infect. Drug Resist, 10(11) : 1645-1658.
Ms And Nikolova Mp Chavali .2019 .Metal oxide nanoparticles and their applications in nanotechnology. Sn Applied Sciences, 1(6) : 607.
Ejaz H,Ahmad M,Younas S,Junaid K,Abosalif Koa,Ahmad N,Qamar Mu N .2021 .Molecular epidemiology of extensively-drug resistant Acinetobacter baumannii sequence type 2 CoHarboring Bla (Ndm) and Bla (Oxa) From Clinical Origin. , 14 : 1931-1939.
Hf Hetta,Al-Kadmy Ims,Abbas S,Suhail A,El-Mokhtar Ma,Abd-Ellatief Rb,El-Masry Ea,Algammal Am Ea .2021 .Antibiofilm and antivirulence potential of silver nanoparticles against multidrug-resistant Acinetobacter baumannii. Sci. Rep, 11(1) : 10751.
Khaled JM,Alharbi NS,Siddiqi MZ,Alobaidi AS,Nauman K,Alahmedi S,Almazyed AO,An AO .2021 .A synergic action of colistin, imipenem, and silver nanoparticles against pandrug-resistant Acinetobacter baumannii isolated from patients. J. Infect. Public Health, 14(11) : 1679-1685.
Khalid F,Saleem S,Ahmad I .2020 .High prevalence of carbapenem-resistant Acinetobacter Baumannii associated respiratory tract infections in pakistani hospitals. J. Pak. Med, 70(9) : 1630-1632.
Maf Khalil,Hosni A,Alghamdi S,Kabrah A,Dablool As,Hefzy Em As .2021 .Virulence characteristics of biofilm-forming Acinetobacter baumannii in clinical isolates using a galleria mellonella model. Microorganisms, 9(11) : 2365.
Khurshid M,Rasool Mh,Azeem F,Naeem M,Sohail M,Sarfraz M,Saqalein M,Taj Z,Nisar Ma,Shahzad A Ma .2019 .Molecular mechanisms of antibiotic co-resistance among carbapenem resistant Acinetobacter baumannii. J. Infect. Dev. Ctries, 13(10) : 899-905.
Kim C,Latif I,Neupane Dp,Batool A,Ahmed Q,Song J Q .2021 .The molecular basis of extensively drug-resistant salmonella typhi isolates from pediatric septicemia patients. Plos One, 16(9) : E0257744.
Mf And Lan Cy Lin .2014 .Antimicrobial resistance in Acinetobacter baumannii: From bench to bedside. World J. Clin. Cases, 2(12) : 787-814.
Park Jm,Yk Jm .2021 .Clinical outcomes and safety of meropenem-colistin versus meropenemtigecycline in patients with carbapenem-resistant Acinetobacter baumannii Pneumonia. Antibiotics, 10(8) : 903.
Nordmann Poirel L,P Poirel L .2006 .Carbapenem resistance in Acinetobacter baumannii: Mechanisms and epidemiology. Clin. Microbiol, 12(9) : 826-836.
Mu Qamar,Ambreen A,Batool A,Rasool Mh,Shafique M,Khan A,Nisar Ma,Khalid A,Junaid K,Ejaz H K .2021 .Molecular detection of extensively drug-resistant Salmonella typhi and carbapenem-resistant pathogens in pediatric septicemia patients in Pakistan - A public health concern. Future Microbiology, 16(10) : 731-739.
Mu Qamar,Saleem S,Aboklaish A,Jahan S A .2019 .-7 producing-gramnegative pathogens isolated from pediatric patients in Pakistan. Future Microbiology, 14(8) : 691-704.
Qureshi R,Qamar Mu,Shafique M,Muzammil S,Rasool Mh,Ejaz H Ahmad I .2021 .Antibacterial efficacy of silver nanoparticles against metallo-β-lactamase (Blandm, Blavim, Blaoxa) producing clinically isolated Pseudomonas Aeruginosa. Pak. J. Pharm. Sci., 34(1 Suppl.) : 237-243.
Saleem Z,Godman B,Azhar F,Kalungia Ac,Fadare J,Opanga S,Markovic-Pekovic V,Hoxha I,Saeed A,AlGethamy M,Haseeb A,Salman M,Khan Aa,Amir A,Ikram A,Hassali M A .2021 .Progress on the national action plan of pakistan on antimicrobial resistance (Amr): A narrative review and the implications. Expert. Rev. Anti. Infect. Ther., : 1-23.
Sharma D,Kanchi S,Bisetty K S .2019 .Biogenic synthesis of nanoparticles: A review. Arab. J. Chem, 12(8) : 3576-3600.
Mu Qamar,Lopes BS,Hassan B,Khurshid M,Shafique M,Atif NM,Mohsin M,Nawaz Z,Muzammil S,Aslam B,Ejaz H,Toleman MA H .2020 .The present danger of New Delhi Metallo-Β-Lactamase: A threat to public health. Future Microbiol, 15(18) : 1759-1778.
Ja Viehman .2014 .Treatment options for carbapenem-resistant and extensively drugresistant Acinetobacter baumannii infections. Drugs, 74(12) : 1315-1333.
Wareth G,Linde J,Nguyen Nh,Neubauer H Nh .2021 .Wgs-based analysis of carbapenem-resistant Acinetobacter baumannii in Vietnam and molecular characterization of antimicrobial determinants and Mlst in Southeast Asia. , 10(5) : 563.
0

Citations

0

Downloads

7

Views